Ranking Profile - Intellia Therapeutics Inc

Introduction

Intellia Therapeutics Inc (Intellia Therapeutics) is a biotechnology company. The company developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. It develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, and primary hyperoxaluria Type 1. Intellia Therapeutics also develops ex vivo programs such as hematopoietic stem cells (HSCs) and chimeric antigen receptor T cells (CAR-T cells). The company’s pipeline products include OTQ923 / HIX763, NTLA-5001. The company conducts genome editing in the fields of immuno-oncology and autoimmune and inflammatory diseases. Intellia Therapeutics is headquartered in Cambridge, Massachusetts, the US.